| Issue |
Med Sci (Paris)
Volume 34, Number 5, Mai 2018
|
|
|---|---|---|
| Page(s) | 383 - 386 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/20183405004 | |
| Published online | 13 June 2018 | |
Traitement des dystrophies rétiniennes affectant l’épithélium pigmentaire par ingénierie tissulaire fondée sur les cellules souches embryonnaires humaines
Treating retinal dystrophies affecting retinal pigment epithelium using tissue engineering obtained from human embryonic stem cells
1
Inserm U861, I-Stem, AFM, Institute for stem cell therapy and exploration of monogenic diseases, 28, rue Henri Desbruères, 91100 Corbeil-Essonnes, France
2
UEVE Inserm U861, I-Stem, AFM, Institute for stem cell therapy and exploration of monogenic diseases, 28, rue Henri Desbruères, 91100 Corbeil-Essonnes, France
3
CECS, I-Stem, AFM, Institute for stem cell therapy and exploration of monogenic diseases, 28, rue Henri Desbruères, 91100 Corbeil-Essonnes, France
4
Institut de la vision, Sorbonne Université, Inserm, CNRS, 75012 Paris, France
a
christelle.monville@univ-evry.fr
b
olivier.goureau@inserm.fr
Cet article ne possède pas de résumé.
© 2018 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
